Previous Close | 732.20 |
Open | 725.00 |
Bid | 723.34 x 1000 |
Ask | 723.81 x 1100 |
Day's Range | 718.30 - 727.99 |
52 Week Range | 380.77 - 800.78 |
Volume | |
Avg. Volume | 3,063,427 |
Market Cap | 689.182B |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | 125.41 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 5.20 (0.71%) |
Ex-Dividend Date | Feb 14, 2024 |
1y Target Est | N/A |
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.